3/12
07:11 pm
tlx
Telix Adds Lead-212 Isotope Production Capability
Low
Report
Telix Adds Lead-212 Isotope Production Capability
3/12
06:48 pm
tlx
Telix Adds Lead-212 Isotope Production Capability
Low
Report
Telix Adds Lead-212 Isotope Production Capability
3/12
06:41 pm
tlx
Telix Adds Lead-212 Isotope Production Capability
Low
Report
Telix Adds Lead-212 Isotope Production Capability
3/12
12:08 pm
tlx
Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ: TLX) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ: TLX) had its "outperform" rating re-affirmed by analysts at William Blair.
3/3
04:58 pm
tlx
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
Medium
Report
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
3/3
04:48 pm
tlx
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
Medium
Report
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
2/25
08:01 pm
tlx
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
Medium
Report
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
2/25
07:49 pm
tlx
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
Medium
Report
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
2/25
06:51 pm
tlx
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
Medium
Report
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
2/25
07:30 am
tlx
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
Medium
Report
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
2/25
04:48 am
tlx
Illuccix® Prostate Cancer Imaging Agent Approved in Luxembourg
Low
Report
Illuccix® Prostate Cancer Imaging Agent Approved in Luxembourg
2/24
01:00 am
tlx
Telix's Illuccix® PSMA-PET Imaging Agent Approved in Norway
Medium
Report
Telix's Illuccix® PSMA-PET Imaging Agent Approved in Norway
2/20
07:35 am
tlx
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
Medium
Report
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
2/20
07:23 am
tlx
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
Medium
Report
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
2/20
07:10 am
tlx
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
Medium
Report
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
2/13
08:07 am
tlx
Illuccix® godkendt i Danmark
Low
Report
Illuccix® godkendt i Danmark
2/13
07:00 am
tlx
Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)
Low
Report
Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)
2/12
04:38 pm
tlx
Illuccix® Approved in the United Kingdom
Low
Report
Illuccix® Approved in the United Kingdom
2/12
04:34 pm
tlx
Illuccix® Approved in the United Kingdom
Low
Report
Illuccix® Approved in the United Kingdom
2/12
04:30 pm
tlx
Illuccix® Approved in the United Kingdom
Low
Report
Illuccix® Approved in the United Kingdom
2/12
05:27 am
tlx
Is Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now? [Yahoo! Finance]
Low
Report
Is Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now? [Yahoo! Finance]
2/11
05:22 am
tlx
Illuccix® Approved in Denmark
Low
Report
Illuccix® Approved in Denmark
1/30
05:01 pm
tlx
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Low
Report
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
1/30
04:57 pm
tlx
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Low
Report
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
1/27
04:43 pm
tlx
Telix Completes Acquisition of RLS (USA) Inc.
Low
Report
Telix Completes Acquisition of RLS (USA) Inc.